Mortality in Cancer Patients Admitted to the Intensive Care Unit in a Resource-limited Setting
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02659839|
Recruitment Status : Completed
First Posted : January 20, 2016
Last Update Posted : October 27, 2016
|Condition or disease||Intervention/treatment|
|Cancer||Other: Cancer patients admitted to the ICU|
The management of cancer patients in the intensive care unit (ICU) has changed dramatically during the last two decades. Initial experiences showed high rates of hospital mortality, reaching up to 75-85% in patients requiring life-sustaining treatments, particularly mechanical ventilation. An increasing number of clinical experiences has been reported pointing to a significant improvement in survival of these patients. However, it is not clear if this results are generalizable to settings with resource constraints. Therefore, the purpose of this study is to determine 30 day mortality in cancer patients admitted to the intensive care unit in a resource limited setting.
This study is a prospective cohort of cancer patients admitted to the ICU in which the investigators will evaluate the prognostic of cancer patients admitted for a ICU trial or treatment in ICU without limitations. This study will not consider any change in the treatment plan of the patients. The source of the data will be the clinical records of the patients during the admission and the records of the cancer unit. There will be no direct contact of the research team with the patients or their family.
|Study Type :||Observational|
|Actual Enrollment :||142 participants|
|Official Title:||Mortality in Cancer Patients Admitted to the Intensive Care Unit in a Resource-limited Setting: A Prospective Cohort Study|
|Study Start Date :||July 2015|
|Actual Primary Completion Date :||October 2016|
|Actual Study Completion Date :||October 2016|
Cancer patients admitted to the ICU
Patients with cancer admitted to the ICU. No intervention will be administered.
Other: Cancer patients admitted to the ICU
There will be no change in the standard ICU treatment.
Other Name: Standard intensive care unit management.
- Mortality at 30 days [ Time Frame: 30 days since ICU admission ]
- Mortality at 180 days [ Time Frame: 180 days since ICU admission ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02659839
|Hospital Dr. Sótero del Rio|
|Santiago, Region Metropolitana, Chile, 8207257|
|Principal Investigator:||Sebastián Mondaca, MD||Pontificia Universidad Catolica de Chile|